Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
A wearable continuous patient monitor called the Radius VSM® has received FDA 510(k) clearance for its OIRD detection feature powered by Masimo smartSET™ and enabled by artificial intelligence in Irvine, California. This approval signifies the device's capability to detect oxygen-induced respiratory depression (OIRD) effectively.